Income Statement (TTM)
American Oncology Network, Inc. - Equity Warrant Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 12-31 |
2021 12-31 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 725 | 944 | 1,098 | 1,150 | 1,191 | 1,216 | 1,255 | 1,279 | 1,340 | 1,459 | 1,593 | 1,759 |
| Change (%) | 30.22 | 16.31 | 4.73 | 3.59 | 2.14 | 3.20 | 1.89 | 4.74 | 8.88 | 9.18 | 10.47 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 652 | 863 | 1,013 | 1,052 | 1,082 | 1,108 | 1,152 | 1,194 | 1,265 | 1,378 | 1,501 | 1,639 |
| Change (%) | 32.48 | 17.26 | 3.86 | 2.86 | 2.48 | 3.90 | 3.64 | 6.00 | 8.95 | 8.91 | 9.17 | |
| % of Revenue | 89.93 | 91.49 | 92.24 | 91.47 | 90.82 | 91.13 | 91.74 | 93.32 | 94.44 | 94.49 | 94.26 | 93.15 |
| Gross Operating Profit | 73 | 80 | 85 | 98 | 109 | 108 | 104 | 86 | 75 | 80 | 91 | 120 |
| Change (%) | 10.05 | 6.13 | 15.14 | 11.39 | -1.23 | -3.95 | -17.51 | -12.87 | 7.82 | 13.85 | 31.74 | |
| % of Revenue | 10.07 | 8.51 | 7.76 | 8.53 | 9.18 | 8.87 | 8.26 | 6.68 | 5.56 | 5.51 | 5.74 | 6.85 |
| SG&A | 51 | 79 | 91 | 89 | 92 | 94 | 96 | 103 | 108 | 121 | 130 | 137 |
| Change (%) | 55.99 | 15.22 | -2.40 | 3.25 | 2.18 | 1.88 | 7.82 | 4.41 | 11.87 | 7.90 | 4.77 | |
| % of Revenue | 7.02 | 8.41 | 8.33 | 7.76 | 7.74 | 7.74 | 7.64 | 8.09 | 8.06 | 8.28 | 8.18 | 7.76 |
| R&D | ||||||||||||
| Change (%) | ||||||||||||
| % of Revenue | ||||||||||||
| OpEx | 703 | 943 | 1,104 | 1,141 | 1,174 | 1,203 | 1,248 | 1,297 | 1,373 | 1,499 | 1,632 | 1,776 |
| Change (%) | 34.18 | 17.09 | 3.34 | 2.89 | 2.46 | 3.74 | 3.96 | 5.87 | 9.18 | 8.83 | 8.82 | |
| % of Revenue | 96.95 | 99.90 | 100.57 | 99.23 | 98.56 | 98.87 | 99.38 | 101.40 | 102.50 | 102.77 | 102.44 | 100.91 |
| Operating Income | 22 | 1 | -6 | 9 | 17 | 14 | 8 | -18 | -33 | -40 | -39 | -16 |
| Change (%) | -95.87 | -785.84 | -241.53 | 93.58 | -19.61 | -43.84 | -331.83 | 86.87 | 20.90 | -3.91 | -58.63 | |
| % of Revenue | 3.05 | 0.10 | -0.57 | 0.77 | 1.44 | 1.13 | 0.62 | -1.40 | -2.50 | -2.77 | -2.44 | -0.91 |
| Interest Expense | -1 | -1 | -2 | -3 | -4 | -5 | -6 | -6 | -7 | -7 | -7 | -7 |
| Change (%) | 27.15 | 69.70 | 41.90 | 29.27 | 19.42 | 11.53 | 9.08 | 5.39 | 4.17 | 4.85 | -4.47 | |
| % of Revenue | -0.15 | -0.15 | -0.22 | -0.30 | -0.37 | -0.43 | -0.47 | -0.50 | -0.50 | -0.48 | -0.46 | -0.40 |
| Net Income | 22 | 0 | -8 | 0 | 6 | 0 | -2 | -6 | -12 | 2 | -9 | -4 |
| Change (%) | -100.00 | -∞ | -100.00 | ∞ | -100.00 | -∞ | 209.26 | 114.67 | -115.37 | -594.20 | -56.05 | |
| % of Revenue | 3.03 | 0.00 | -0.77 | 0.00 | 0.47 | 0.00 | -0.14 | -0.43 | -0.89 | 0.13 | -0.57 | -0.23 |
Source: Capital IQ
